Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19

Details

Instance of

clinical trial

Start time

6 April 2020

End time

1 October 2020

Country

Brazil

Main subject

ACE inhibitor, severe acute respiratory syndrome

minimum age

18

number of participants

500

research intervention

ACE inhibitor, angiotensin receptor antagonist

research subject recruitment status

recruiting

short name

BRACE-CORONA

study type

interventional study

title

Suspension of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Hospitalized Patients With Coronavirus Infection (COVID-19). A Randomized Trial